{
  "pmcid": "11895797",
  "sha256": "c6d8d41133e9c7d185cb9fcbd2ed29c6b33a35d7536592473f7bc8e2cbeabd53",
  "timestamp_utc": "2025-11-09T15:25:42.497117+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.593636363636364,
    "reading_ease": 45.387496147919904,
    "word_count": 236
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Sixty patients undergoing appendectomy operations were randomized in 3 groups."
      },
      "Participants": {
        "score": 1,
        "evidence": "This study was conducted in Shahid Mohamadi Hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Group A received intravenous Dexmedetomidine bolus (1 μg/kg) and infusion (0.5 μg/kg/h). Group B received slow intravenous bolus ketorolac 30 mg. Group C was the control group."
      },
      "Objective": {
        "score": 1,
        "evidence": "The primary objective was to test the hypothesis that the preemptive/preventive effect of Dexmedetomidine would attenuate the post-operative pain more effectively compared to ketorolac and control groups."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the Visual Analogue Scale (VAS) pain scores recorded at 1, 3, 6, 12 and 24 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Sixty patients undergoing appendectomy operations were randomized in 3 groups."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Sixty patients undergoing appendectomy operations were randomized in 3 groups."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "In the Dexmedetomidine group the mean ± SD pain VAS scores 1.15 ± 1.98 and 0.95 ± 1.76 were significantly lower at 12 and 24 hours after operation (P = 0.004 and P = 0.003) compared to the other two (ketorolac and control) groups."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}